The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Ardent Health Inc (NYSE: ARDT) closed at $10.51 down -4.02% from its previous closing price of $10.95. In other words, the price has decreased by -$4.02 from its previous closing price. On the day, 0.79 million shares were traded. ARDT stock price reached its highest trading level at $11.15 during the session, while it also had its lowest trading level at $10.48.
Ratios:
For a deeper understanding of Ardent Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.70. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.12. In the meantime, Its Debt-to-Equity ratio is 1.94 whereas as Long-Term Debt/Eq ratio is at 1.92.
BofA Securities Downgraded its Buy to Neutral on November 06, 2024, whereas the target price for the stock was revised from $22 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 08 ’24 when Webb Robert Thomas bought 20,000 shares for $16.98 per share. The transaction valued at 339,600 led to the insider holds 40,275 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDT now has a Market Capitalization of 1503392512 and an Enterprise Value of 3669964800. As of this moment, Ardent’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.66, and their Forward P/E ratio for the next fiscal year is 5.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 0.609 whereas that against EBITDA is 6.744.
Stock Price History:
The Beta on a monthly basis for ARDT is 0.27, which has changed by -0.3725373 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, ARDT has reached a high of $20.72, while it has fallen to a 52-week low of $10.90. The 50-Day Moving Average of the stock is -23.72%, while the 200-Day Moving Average is calculated to be -29.82%.
Shares Statistics:
For the past three months, ARDT has traded an average of 323.88K shares per day and 557220 over the past ten days. A total of 143.04M shares are outstanding, with a floating share count of 22.71M. Insiders hold about 84.12% of the company’s shares, while institutions hold 12.13% stake in the company. Shares short for ARDT as of 1751241600 were 1667677 with a Short Ratio of 5.15, compared to 1748563200 on 1577484. Therefore, it implies a Short% of Shares Outstanding of 1667677 and a Short% of Float of 5.0200000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Current recommendations for the stock of the company come from 7.0 analysts. The consensus estimate for the next quarter is $0.68, with high estimates of $0.81 and low estimates of $0.38.
Analysts are recommending an EPS of between $2.21 and $1.88 for the fiscal current year, implying an average EPS of $2.03. EPS for the following year is $2.11, with 8.0 analysts recommending between $2.32 and $1.87.
Revenue Estimates
A total of 9 analysts believe the company’s revenue will be $1.54B this quarter.It ranges from a high estimate of $1.6B to a low estimate of $1.49B. As of the current estimate, Ardent Health Inc’s year-ago sales were $1.47BFor the next quarter, 9 analysts are estimating revenue of $1.62B. There is a high estimate of $1.73B for the next quarter, whereas the lowest estimate is $1.53B.
A total of 11 analysts have provided revenue estimates for ARDT’s current fiscal year. The highest revenue estimate was $6.37B, while the lowest revenue estimate was $6.31B, resulting in an average revenue estimate of $6.33B. In the same quarter a year ago, actual revenue was $5.97BBased on 11 analysts’ estimates, the company’s revenue will be $6.66B in the next fiscal year. The high estimate is $6.74B and the low estimate is $6.44B.
